Depression, Anxiety, Health Care Costs, and Utilization among Patients with Hyperhidrosis in a Real‑World Database Analysis

Main Article Content

M Hull
KK Gillard
J Peterson-Brandt
SZ Klein


Hyperhidrosis, Depression, Anxiety, Health Care Costs


Abstract not available.


1. Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 2016; 308(10):743‑749.

2. Smith CC, Pariser D. Primary focal hyperhidrosis. Up‑to‑date 2018:‑focal‑hyperhidrosis?search=hyperhidrosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.

3. Bahar R, Zhou P, Liu Y, Huang Y, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75:1126‑1133.

4. Braganca GM, Lima SO, Pinto Neto AF, et al. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras Dermatol. 2014;89(2):230‑235.

5. Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients’ daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes. 2017;15(1):121.

6. Clinical Classification Software (CCS) for ICD‑9‑CM/ICD‑10‑CM. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup‑